ECSP982359A - PHARMACEUTICAL DOSAGE FORM THAT MASKS FLAVOR AND RELEASES QUICKLY - Google Patents

PHARMACEUTICAL DOSAGE FORM THAT MASKS FLAVOR AND RELEASES QUICKLY

Info

Publication number
ECSP982359A
ECSP982359A ECSP982359A ECSP982359A EC SP982359 A ECSP982359 A EC SP982359A EC SP982359 A ECSP982359 A EC SP982359A EC SP982359 A ECSP982359 A EC SP982359A
Authority
EC
Ecuador
Prior art keywords
dosage form
pharmaceutical dosage
masks
flavor
core
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Itoh Akinori
Niwa Toshiyudi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982359 priority Critical patent/ECSP982359A/en
Publication of ECSP982359A publication Critical patent/ECSP982359A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención proporciona una forma de dosificación farmacéutica que enmascara el sabor y que se libera rápidamente, que comprende un núcleo que contiene un ingrediente farmacéuticamente activo, hidroxipropilcelulosa poco sustituída y celulosa microcristalina, siendo la cantidad de la celulosa microcristalina por lo menos un 26,0 por ciento en peso, basado en el peso total del núcleo; una capa de un recubrimiento interior, formada sobre el núcleo que contiene un polímero soluble en agua; y una capa del recubrimiento interior y que contiene un polímero insoluble en la saliva, también se describe un procedimiento para preparar dicha forma de dosificación oral.The present invention provides a fast-releasing, taste-masking pharmaceutical dosage form comprising a core containing a pharmaceutically active ingredient, poorly substituted hydroxypropyl cellulose and microcrystalline cellulose, the amount of the microcrystalline cellulose being at least 26, 0 percent by weight, based on the total weight of the core; an inner liner layer formed on the core containing a water soluble polymer; and a layer of the inner liner and containing a polymer insoluble in saliva, a procedure for preparing such an oral dosage form is also described.

ECSP982359 1998-01-06 1998-01-06 PHARMACEUTICAL DOSAGE FORM THAT MASKS FLAVOR AND RELEASES QUICKLY ECSP982359A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982359 ECSP982359A (en) 1998-01-06 1998-01-06 PHARMACEUTICAL DOSAGE FORM THAT MASKS FLAVOR AND RELEASES QUICKLY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982359 ECSP982359A (en) 1998-01-06 1998-01-06 PHARMACEUTICAL DOSAGE FORM THAT MASKS FLAVOR AND RELEASES QUICKLY

Publications (1)

Publication Number Publication Date
ECSP982359A true ECSP982359A (en) 1998-12-22

Family

ID=42043282

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982359 ECSP982359A (en) 1998-01-06 1998-01-06 PHARMACEUTICAL DOSAGE FORM THAT MASKS FLAVOR AND RELEASES QUICKLY

Country Status (1)

Country Link
EC (1) ECSP982359A (en)

Similar Documents

Publication Publication Date Title
CO4650099A1 (en) PHARMACEUTICAL DOSAGE FORM THAT MASKS FLAVOR AND RELEASES QUICKLY
ES2411179T3 (en) Buprenorphine Wafer for Drug Substitution Therapy
UY25544A1 (en) NEFAZODONE DOSAGE FORM
BRPI0411986A (en) multiparticulate pharmaceutical dosage form containing mucoadhesively formulated active peptide or protein substances and a method for producing said pharmaceutical dosage form
MX2007000008A (en) Oral dosage form safeguarded against abuse containing (1r, 2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol.
BRPI0513300A (en) oral dosage form, protected from abuse, containing (1r, 2r) -3- (3-dimethylamino-1-ethyl-2-propyl) -phenol
CO4940409A1 (en) COVERED TABLET WITH FILM FOR IMPROVED SAFETY OF THE UPPER GASTROINTESTINAL TRACT
CY1105908T1 (en) BENZIMIDAZOLE ORODICALLY DISPERSIBLE TABLETS
EE9900288A (en) Use of an Oral Pharmaceutical Composition for the manufacture of a medicament for the treatment of erectile dysfunction in men
EE05022B1 (en) Use of Pregelatinised Starch in a Hydrophilic Controlled Release Preparation and a Hydrophilic Controlled Release Preparation
RU2000131897A (en) ORAL DOSING COMPOSITION OF PROLONGED ACTION
DE60121570D1 (en) ORAL FASCINATING, FIXED PHARMACEUTICAL FORMS TO BE APPLIED ORIGINALLY
CO5170471A1 (en) MODIFIED RELEASE TABLETS INCLUDING AMOXYLIN AND POTASSIUM CLAVULANATE
HUP0203451A2 (en) Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
AR022589A1 (en) A CAPSULE THAT INCLUDES A SPONTANELY DISPERSABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, A SPONTANELY DISPERSABLE PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION AND THE USE FOR THE PREPARATION OF A TREATMENT MEDICATION
UY25234A1 (en) VENLAFAXINE PROLONGED RELEASE FORMULATION
BR0114100A (en) Controlled release formulations for oral administration
AR020780A1 (en) PHARMACEUTICAL COMPOSITION OF SUSTAINED LIBERATION, AND METHOD TO RELEASE A PHARMACEUTICALLY ACTIVE AGENT
AR032642A1 (en) CHEMOTHERAPICAL COMPOSITIONS OF PACLITAXEL IN MICROEMULSION WITH GREATER ORAL BIODISPONIBILITY.
ECSP982359A (en) PHARMACEUTICAL DOSAGE FORM THAT MASKS FLAVOR AND RELEASES QUICKLY
CO5251412A1 (en) MIRTAZAPINE PHARMACEUTICAL COMPOSITION FOR PERORAL ADMINISTRATION WITH POLYMER COVER
HN2001000038A (en) CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE
UY28457A1 (en) NEW COMPOSITION
HUP0401599A2 (en) Extended release oral dosage form
HUP0400495A2 (en) Oral mucosal dosage forms of apomorphine, suitable for the administration via oral mucosal tissue